Human Molecular Genetics Advance Access published online on April 6, 2004
Human Molecular Genetics, doi:10.1093/hmg/ddh128
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305-5120
* To whom correspondence should be addressed. E-mail: vollrath{at}genome.stanford.edu.
Glaucoma is a progressive blinding disease characterized by gradual loss of vision due to optic neuropathy and retinal ganglion cell death. Increased intraocular pressure is a common feature of glaucoma that is thought to arise from an increased resistance to outflow of aqueous humor through the trabecular meshwork. Mutations of the myocilin gene are one cause of autosomal dominant juvenile and adult-onset primary open angle glaucoma, but the mechanism by which mutant myocilins cause disease is poorly understood. We have found that disease-causing myocilin mutants are misfolded, are highly aggregation-prone, and accumulate in large aggregates in the endoplasmic reticulum (ER) of human embryonic kidney cells and differentiated primary human trabecular meshwork (HTM) cells. In HTM cells, Pro370Leu mutant myocilin is not secreted under normal culture conditions and prolonged expression results in abnormal cell morphology and cell killing. Culturing HTM cells at 30°C, a condition known to facilitate protein folding, promotes secretion of mutant myocilin, normalizes cell morphology and reverses cell lethality. Our results indicate that myocilin-associated glaucoma is an ER storage disease and suggest a progression of events in which chronic expression of misfolded, non-secreted myocilin leads to HTM cell death, trabecular meshwork dysfunction, and ultimately, a dominant glaucoma phenotype. The beneficial effects of facilitating folding and secretion of mutant myocilin suggest a new type of treatment for this form of glaucoma.
Article
Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. M. Skarie and B. A. Link The Primary open-angle glaucoma gene WDR36 functions in ribosomal RNA processing and interacts with the p53 stress-response pathway Hum. Mol. Genet., August 15, 2008; 17(16): 2474 - 2485. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nakaya, H.-S. Lee, Y. Takada, I. Tzchori, and S. I. Tomarev Zebrafish Olfactomedin 1 Regulates Retinal Axon Elongation In Vivo and Is a Modulator of Wnt Signaling Pathway J. Neurosci., July 30, 2008; 28(31): 7900 - 7910. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhou, O. Grinchuk, and S. I. Tomarev Transgenic Mice Expressing the Tyr437His Mutant of Human Myocilin Protein Develop Glaucoma Invest. Ophthalmol. Vis. Sci., May 1, 2008; 49(5): 1932 - 1939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. W. Rozsa, K. Scott, H. Pawar, S. Moroi, and J. E. Richards Effects of Timolol on MYOC, OPTN, and WDR36 RNA Levels Arch Ophthalmol, January 1, 2008; 126(1): 86 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.-C. Park, M. Tibudan, M. Samaraweera, X. Shen, and B. Y.J.T. Yue Interaction between two glaucoma genes, optineurin and myocilin Genes Cells, August 1, 2007; 12(8): 969 - 979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Sodium 4-Phenylbutyrate Acts as a Chemical Chaperone on Misfolded Myocilin to Rescue Cells from Endoplasmic Reticulum Stress and Apoptosis Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1683 - 1690. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Shepard, N. Jacobson, J. C. Millar, I.-H. Pang, H. T. Steely, C. C. Searby, V. C. Sheffield, E. M. Stone, and A. F. Clark Glaucoma-causing myocilin mutants require the Peroxisomal targeting signal-1 receptor (PTS1R) to elevate intraocular pressure Hum. Mol. Genet., March 15, 2007; 16(6): 609 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. W. Hewitt, S. L. Bennett, J. H. Fingert, R. L. Cooper, E. M. Stone, J. E. Craig, and D. A. Mackey The Optic Nerve Head in Myocilin Glaucoma Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 238 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Wiggs Genetic Etiologies of Glaucoma Arch Ophthalmol, January 1, 2007; 125(1): 30 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. H.-F. Yam, K. Gaplovska-Kysela, C. Zuber, and J. Roth Aggregated Myocilin Induces Russell Bodies and Causes Apoptosis: Implications for the Pathogenesis of Myocilin-Caused Primary Open-Angle Glaucoma Am. J. Pathol., January 1, 2007; 170(1): 100 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. Gould, M. Reedy, L. A. Wilson, R. S. Smith, R. L. Johnson, and S. W. M. John Mutant Myocilin Nonsecretion In Vivo Is Not Sufficient To Cause Glaucoma Mol. Cell. Biol., November 15, 2006; 26(22): 8427 - 8436. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Senatorov, I. Malyukova, R. Fariss, E. F. Wawrousek, S. Swaminathan, S. K. Sharan, and S. Tomarev Expression of Mutated Mouse Myocilin Induces Open-Angle Glaucoma in Transgenic Mice. J. Neurosci., November 15, 2006; 26(46): 11903 - 11914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Kruse, A. Dear, E. R. Kaltenbrun, B. E. Crum, P. M. George, S. O. Brennan, and A. A. McCracken Mutant Fibrinogen Cleared from the Endoplasmic Reticulum via Endoplasmic Reticulum-Associated Protein Degradation and Autophagy: An Explanation for Liver Disease Am. J. Pathol., April 1, 2006; 168(4): 1299 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Malyukova, H.-S. Lee, R. N. Fariss, and S. I. Tomarev Mutated Mouse and Human Myocilins Have Similar Properties and Do Not Block General Secretory Pathway Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 206 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Fan, D. Y. L. Leung, D. Y. Wang, S. Gobeil, V. Raymond, P. O. S. Tam, D. S. C. Lam, and C. P. Pang Novel Myocilin Mutation in a Chinese Family With Juvenile-Onset Open-Angle Glaucoma Arch Ophthalmol, January 1, 2006; 124(1): 102 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J A Alvarado, R G Alvarado, R F Yeh, L Franse-Carman, G R Marcellino, and M J Brownstein A new insight into the cellular regulation of aqueous outflow: how trabecular meshwork endothelial cells drive a mechanism that regulates the permeability of Schlemm's canal endothelial cells Br. J. Ophthalmol., November 1, 2005; 89(11): 1500 - 1505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Grinchuk, Z. Kozmik, X. Wu, and S. Tomarev The Optimedin Gene Is a Downstream Target of Pax6 J. Biol. Chem., October 21, 2005; 280(42): 35228 - 35237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. M. John Mechanistic Insights into Glaucoma Provided by Experimental Genetics The Cogan Lecture Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2650 - 2661. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Aroca-Aguilar, F. Sanchez-Sanchez, S. Ghosh, M. Coca-Prados, and J. Escribano Myocilin Mutations Causing Glaucoma Inhibit the Intracellular Endoproteolytic Cleavage of Myocilin between Amino Acids Arg226 and Ile227 J. Biol. Chem., June 3, 2005; 280(22): 21043 - 21051. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zillig, A. Wurm, F. J. Grehn, P. Russell, and E. R. Tamm Overexpression and Properties of Wild-Type and Tyr437His Mutated Myocilin in the Eyes of Transgenic Mice Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 223 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gobeil, M.-A. Rodrigue, S. Moisan, T. D. Nguyen, J. R. Polansky, J. Morissette, and V. Raymond Intracellular Sequestration of Hetero-oligomers Formed by Wild-Type and Glaucoma-Causing Myocilin Mutants Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3560 - 3567. [Abstract] [Full Text] [PDF]
|
|